As dienogest effectively suppresses endometriosis, could it also reduce endometriosis-associated ovarian cancers? A further motivation for long-term medical treatment WCRJ 2015; 2 (2) : e526
Clinically relevant of Cytochrome P450 Family enzymes for drug-drug interaction in anticancer therapy WCRJ 2015; 2 (2) : e524
Role of traslational research in squamous cell carcinoma of the head and neck: is it possible to improve the therapeutic scenario? WCRJ 2015; 2 (2) : e520
Selected Pharmacogenetic panel test for toxicity prevention of drug-drug interactions between Highly Active Antiretroviral Therapy (HAART) and antiblastic chemotherapy WCRJ 2015; 2 (1) : e492
Hepatocellular carcinoma: an overview of clinico-pathological and molecular perspectives WCRJ 2015; 2 (1) : e485
Pharmacogenomics of Cytochrome P450 Family enzymes: implications for drug-drug interaction in anticancer therapy WCRJ 2015; 2 (1) : e483
Malignant hepatic tumors in pediatric patients: clinical and radiological features WCRJ 2015; 2 (1) : e481
Pre-operative chemotherapy for colorectal cancer with liver metastases and conversion therapy WCRJ 2015; 2 (1) : e473